Olympiad Research’s GoodRx Holdings GDRX Stock Holding History

Olympiad Research’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-31,530	Closed	-$147K	–	286
2024 Q4	$147K	Buy	+31,530	New	+$173K	0.15%	210
2024 Q3	–	Sell	-16,018	Closed	-$125K	–	385
2024 Q2	$125K	Buy	16,018 +2,917	+22%	+$21.6K	0.09%	327
2024 Q1	$93K	Sell	13,101 -47,296	-78%	-$313K	0.06%	341
2023 Q4	$405K	Buy	60,397 +10,213	+20%	+$57.5K	0.32%	97
2023 Q3	$283K	Buy	50,184 +18,009	+56%	+$120K	0.28%	138
2023 Q2	$178K	Buy	32,175 +13,766	+75%	+$74.1K	0.18%	230
2023 Q1	$115K	Buy	+18,409	New	+$103K	0.13%	193
2022 Q3	–	Sell	-17,397	Closed	-$103K	–	284
2022 Q2	$103K	Buy	17,397 +4,612	+36%	+$51.3K	0.05%	243
2022 Q1	$247K	Buy	+12,785	New	+$293K	0.08%	230

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

8KM

8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return

Olympiad Research's GDRX Position: Q1 2025 in Review

Olympiad Research sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 31,530 shares — an estimated $147K sold.

Olympiad Research first reported a position in GDRX in Q1 2022 and held it in 9 quarters. The position peaked at $405K in Q4 2023. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

Olympiad Research reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
Olympiad Research sold 31,530 GoodRx Holdings shares in Q1 2025, an estimated $147K.
Olympiad Research first reported a position in GoodRx Holdings in Q1 2022 and held it in 9 quarters.
Olympiad Research's GoodRx Holdings position peaked at $405K in Q4 2023.
170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Olympiad Research's 13F filing for Q1 2025, filed 13 May 2025.